国家: 爱尔兰
语言: 英文
来源: HPRA (Health Products Regulatory Authority)
Midodrine hydrochloride
PCO Manufacturing Ltd.
C01CA; C01CA17
Midodrine hydrochloride
2.5 milligram(s)
Tablet
Product subject to prescription which may be renewed (B)
Adrenergic and dopaminergic agents; midodrine
Authorised
2011-07-22
_ _ PACKAGE LEAFLET: INFORMATION FOR THE USER MIDON ® 2.5 MG TABLETS midodrine hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist.This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Midon Tablets are and what they are used for 2. What you need to know before you take Midon Tablets 3. How to take Midon Tablets 4. Possible side effects 5. How to store Midon Tablets 6. Contents of the pack and other information 1. WHAT MIDON TABLETS ARE AND WHAT THEY ARE USED FOR Midon Tablets contain the active ingredient midodrine hydrochloride, which acts on the blood vessels via the sympathetic nervous system to correct imbalances of blood distribution, such as preventing too much blood pooling in the legs when standing up. Midon Tablets are used to stop the fall in your blood pressure as a result of your sympathetic nervous system not working correctly. This should help to relieve the symptoms which you might be suffering such as dizziness, fainting, blurred vision and weakness when you sit or stand up. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MIDON TABLETS DO NOT TAKE THE TABLETS IF YOU: are allergic (hypersensitive) to midodrine hydrochloride or any of the other ingredients in the tablets (_see Section 6_) have a tumour near the kidney, known as phaeochromocytoma suffer from the eye disease narrow angle glaucoma have thyroid gland problems called thyrotoxicosis or hyperthyroidism i.e. overactive thyroid suffer from high blood pressure or a form of low blood pressure known as vasovagal hypotension some types of heart or blood 阅读完整的文件
Health Products Regulatory Authority 12 July 2022 CRN00D0NW Page 1 of 3 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Midon 2.5 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2.5 mg midodrine hydrochloride. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet _Product imported from Germany and Bulgaria _ Round, white, biplanar tablets with bevelled edge. Scored on one side with 'GU' above and '2.5' below the score. _Product imported from Italy_ Round, white, tablets. Scored on one side with 'Gutron' and a star symbol on the other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS Asper PA 2239/016/001 5 PHARMACOLOGICAL PROPERTIES Asper PA 2239/016/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS _Product imported from Germany and Bulgaria _ Magnesium stearate Talc Colloidal anhydrous silica Microcrystalline cellulose Maize starch _Product imported from Italy_ Magnesium stearate Talc Colloidal anhydrous silica Microcrystalline cellulose Starch 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE Health Products Regulatory Authority 12 July 2022 CRN00D0NW Page 2 of 3 The shelf life expiry date of this product shall be the date shown on the blister and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25 ºC. Store in the original package in order to protect from moisture and light. 6.5 NATURE AND CONTENTS OF CONTAINER _Product imported from Germany and Bulgaria_ 10 blisters of 10 tablets - pack size 100 tablets. _Product imported from Italy_ 6 blisters of 15 tablets - pack size 90 tablets Not all pack sizes may be marketed. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. Health Products Regulatory Authority 12 July 2022 CRN00D0NW Page 3 of 3 7 PARALLEL 阅读完整的文件